Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eglė Ereminienė is active.

Publication


Featured researches published by Eglė Ereminienė.


International Journal of Experimental Pathology | 2015

Exogenous connexin43‐expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction

Ieva Antanavičiūtė; Eglė Ereminienė; Vaidas Vysockas; Mindaugas Račkauskas; Vilius Skipskis; Kristina Rysevaitė; Rimantas Treinys; Rimantas Benetis; Jonas Jurevičius; Vytenis A. Skeberdis

Acute myocardial infarction is one of the major causes of mortality worldwide. For regeneration of the rabbit heart after experimentally induced infarction we used autologous skeletal myoblasts (SMs) due to their high proliferative potential, resistance to ischaemia and absence of immunological and ethical concerns. The cells were characterized with muscle‐specific and myogenic markers. Cell transplantation was performed by injection of cell suspension (0.5 ml) containing approximately 6 million myoblasts into the infarction zone. The animals were divided into four groups: (i) no injection; (ii) sham injected; (iii) injected with wild‐type SMs; and (iv) injected with SMs expressing connexin43 fused with green fluorescent protein (Cx43EGFP). Left ventricular ejection fraction (LVEF) was evaluated by 2D echocardiography in vivo before infarction, when myocardium has stabilized after infarction, and 3 months after infarction. Electrical activity in the healthy and infarction zones of the heart was examined ex vivo in Langendorff‐perfused hearts by optical mapping using di‐4‐ANEPPS, a potential sensitive fluorescent dye. We demonstrate that SMs in the coculture can couple electrically not only to abutted but also to remote acutely isolated allogenic cardiac myocytes through membranous tunnelling tubes. The beneficial effect of cellular therapy on LVEF and electrical activity was observed in the group of animals injected with Cx43EGFP‐expressing SMs. L‐type Ca2+ current amplitude was approximately fivefold smaller in the isolated SMs compared to healthy myocytes suggesting that limited recovery of LVEF may be related to inadequate expression or function of L‐type Ca2+ channels in transplanted differentiating SMs.


Medicina-buenos Aires | 2014

Takotsubo cardiomyopathy: the challenging diagnosis in clinical routine.

Eglė Kazakauskaitė; Antanas Jankauskas; Tomas Lapinskas; Rasa Ordienė; Eglė Ereminienė

Takotsubo cardiomyopathy is rapidly reversible heart failure syndrome that usually mimics the symptoms of acute myocardial infarction with the characteristic regional wall-motion abnormalities (classically with a virtual apical ballooning caused by hypokinetic or akinetic apical or midventricular myocardium and hypercontraction of the basal segments) and absence of obstructive coronary artery disease. TC is usually associated with identifiable emotional, psychological or physical stress event and most commonly appears in postmenopausal women. The certain pathophysiological mechanism remains unknown. However, the central hypothesis is supported by the excess of catecholamines and hyperactivity of nervous system. In the last decades the frequency of the TC diagnosis is increasing rapidly but at the initial presentation the diagnosis remains challenging due to the close similarities between TC and ST elevation myocardial infarction clinical presentations that consider TC as an important part of differential diagnosis in acute coronary syndrome.


Medicina-lithuania | 2013

Prognosis of in-hospital myocardial infarction course for diabetic and nondiabetic patients using a noninvasive evaluation of hemodynamics and heart rate variability.

Rūta Ablonskytė-Dūdonienė; Giedrė Bakšytė; Indrė Čeponienė; Algimantas Krisciukaitis; Kęstutis Drėgūnas; Eglė Ereminienė

BACKGROUND AND OBJECTIVE The objective of our study was to investigate whether the combination of markers of heart rate variability (HRV) and impedance cardiography (ICG) help evaluate the risk of in-hospital death, ventricular arrhythmia, or complicated course secondary to myocardial infarction (STEMI) and to clarify whether combined analysis of HRV and ICG improve prognosis of STEMI, comparing 3 groups: 1) diabetic, 2) nondiabetic, and 3) diabetes-unselected patients. MATERIAL AND METHODS The parameters reflecting heart rate variability and central hemodynamics were estimated from a 24-hour synchronic electrocardiogram and thoracic impedance signal recordings in 232 patients (67 diabetic) on the third day after myocardial infarction. Logistic regression analysis was used to determine the predictors of selected outcomes. Different prognostic models were compared with the receiver operating characteristic curve analysis. RESULTS The model consisting of low- and high-frequency power ratio (LF/HF) and cardiac output (CO) was elaborated for the prognosis of in-hospital death in the group 3 (odds ratios [ORs] were 9.74 and 4.85, respectively). Very low-frequency power (VLF), cardiac index (CIN), and cardiac power output (CPO) were the predictors of ventricular arrhythmia in the group 2 (ORs of 1.005, 5.09, and 66.7, respectively) and the group 3 (ORs of 1.004, 3.84, and 37.04, respectively). The predictors of the complicated in-hospital course in the group 1 were the baseline width of the minimum square difference triangular interpolation of the highest peak of the histogram of all NN intervals (TINN) and stroke volume (SV) (ORs of 1.006, and 1.009, respectively); in the group 2, the mean of the standard deviations of all NN intervals for all 5-minute segments of the recording (SDNN index) and CPO (ORs of 1.06 and 2.44, respectively); and in the group 3, SDNN index, VLF, LF/HF, CIN (ORs of 1.04, 1.004, 2.3, and 3.49, respectively). CONCLUSIONS The patients with decreased HRV and low estimates of central hemodynamics evaluated by ICG are at an increased risk of the adverse in-hospital course of STEMI. The combined analysis of HRV and ICG hemodynamic estimates contributes to the risk assessment of the complicated in-hospital course of STEMI, in-hospital hemodynamically significant ventricular arrhythmia, and in-hospital death secondary to STEMI. The in-hospital prognostic value of the combined estimates of HRV and ICG is lower in the STEMI patients with diabetes mellitus as compared with the nondiabetic patients.


Medicina-buenos Aires | 2018

Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis

Birutė Gumauskienė; Aušra Krivickienė; Regina Jonkaitienė; Jolanta Justina Vaškelytė; Adakrius Siudikas; Eglė Ereminienė

Background: Severe aortic stenosis (AS) complicated by pulmonary hypertension (PH) is associated with poor outcomes after surgical aortic valve replacement (AVR). There is still scarce information about predictors of secondary PH in this group of patients. Objectives: The aim of this study was to investigate the prognostic impact of biomarkers together with conventional Doppler echocardiographic parameters of left ventricular diastolic function on elevated pulmonary systolic pressure (PSP) in severe AS patients before surgical AVR. Methods: Sixty patients with severe isolated AS (aortic valve area <1 cm2) underwent echocardiography, N-terminal pro B-type natriuretic peptide (NT-proBNP) and growth differentiation factor-15 (GDF-15) measurements before AVR. PSP, left ventricular ejection fraction (LV EF), parameters of LV diastolic function (E/E’ ratio, mitral valve deceleration time (MV DT) and left atrial (LA) volume) were evaluated. PH was defined as an estimated PSP ≥ 45 mmHg. Results: Of the 60 patients, 21.7% with severe isolated AS had PH with PSP ≥ 45 mmHg (58.5 ± 11.2 mmHg). LV EF did not differ between groups and was not related to an elevated PSP (50 ± 8 vs. 49 ± 8%, p = 0.58). Parameters of LV diastolic dysfunction (E/E’ ratio > 14 (OR 6.00; 95% CI, 1.41–25.48; p = 0.009), MV DT ≤ 177.5 ms (OR 9.31; 95% CI, 2.06–41.14; p = 0.001), LA volume > 100 mL (OR 9.70; 95% CI, 1.92–49.03; p = 0.002)) and biomarkers (NT-proBNP > 4060 ng/L (OR 12.54; 95% CI, 2.80–55.99; p < 0.001) and GDF-15 > 3393 pg/mL (OR 18.33; 95% CI, 2.39–140.39; p = 0.001)) were significantly associated with elevated PSP in severe AS. Conclusions: Left ventricular diastolic dysfunction and elevated biomarkers levels could predict the development of pulmonary hypertension in patients with severe aortic stenosis. Elevation of biomarkers paired with worsening of LV diastolic dysfunction could help to stratify patients for earlier surgical treatment before the development of pulmonary hypertension.


Medicina-buenos Aires | 2017

Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction

Rūta Žvirblytė; Eglė Ereminienė; Aistė Montvilaitė; Antanas Jankauskas; Vytenis Ivanauskas

Cardiovascular abnormalities are well-known manifestations of a late form of syphilis - tertiary syphilis. Since the era of antibiotics, the incidence of late manifestations of syphilis has declined almost to a rare entity. The injury of aorta (the aortitis with a dilatation of aortic root and its associated complications) is the most common between all the cardiovascular lesions. A less common manifestation of syphilitic aortitis is coronary artery ostial narrowing related to aortic wall thickening. We present the case of a 37-year-old male who was treated for an acute myocardial infarction due to bilateral coronary artery ostial stenosis secondary to syphilitic aortitis. According to the multidisciplinary decision, surgical revascularization (coronary artery bypass grafting, CABG) was performed. According to dermatologist recommendation, patient postoperative cardiovascular treatment was supplemented with intramuscular doses of benzathine penicillin recommended for tertiary syphilis. Further follow-up visits were also planned to detect possible changes of the aortic wall, dynamics of aortic regurgitation or potential anastomotic restenosis due to progression of aortitis.


Perfusion | 2016

Non-ischaemic mitral valve suture annuloplasty: late follow-up results

Rimantas Benetis; Paulius Orda; Jolanta Justina Vaškelytė; Vytenis Ivanauskas; Eglė Ereminienė; Povilas Jakuška; Loreta Jankauskienė

Objective: To evaluate late outcomes after posterior mitral valve (MV) annulus double-suture annuloplasty for degenerative (non-ischaemic) MV insufficiency. Design: Between 2005 and 2011, 138 patients underwent MV repair using posterior MV double-suture annuloplasty and an additional 105 patients underwent tricuspid valve repair. The study protocol included operative mortality, reoperation rate and reasons, as well as echocardiographic parameters at pre- and postoperative and follow-up periods (2-9 years). Results: In-hospital mortality was 2/138 (1.45%). Early post operation, no regurgitation was noted in 74/136 (54.4%) patients, Io regurgitation was observed in 55/136 (40.4%), IIo was observed in 6/136 (4.4%) and IIIo was observed in 1/136 (0.7%); during late follow-up (from 2 to 9 years), no regurgitation was observed in 21.6% patients, Io was observed in 58%, IIo was observed in 17% and IIIo was observed in 3.4%. The mean preoperative anterolateral diameter of the MV annulus was 39.02±4.97 mm and, at late follow-up, it was 27.66±3.94 mm (p=0.000); at these same time points, left ventricular end-diastolic diameter (LVEDD) was 55.74±7.29 mm and 49.17±6.01 mm (p=0.000), respectively, and the left ventricular ejection fraction (LVEF) was 53.08±8.93% and 50.92±6.78%, respectively (p=0.007). Conclusions: This study demonstrates suture annuloplasty to be an effective treatment up to 9 years for degenerative mitral valve disease. This technique enables preservation of the posterior mitral valve annulus diameter with stable long-term (up to 9 years) reduction, a competent (no regurgitation/⩽IIo regurgitation) MV in 96.6% of cases and positive left ventricular (LV) remodelling.


Medicina-buenos Aires | 2012

Impedance Cardiography and Heart Rate Variability for Long-Term Cardiovascular Outcome Prediction After Myocardial Infarction

Rūta Ablonskytė-Dūdonienė; Giedrė Bakšytė; Indrė Čeponienė; Algimantas Krisciukaitis; Kęstutis Drėgūnas; Eglė Ereminienė


Public Health | 2018

LEFT VENTRICULAR ASSIST DEVICE WITH CONCOMINANT TRICUSPID VALVE REPAIR: IMPACT ON RIGHT VENTRICULAR REVERSE REMODELLING AND SURVIVAL

Povilas Jakuška; Rasa Veisaitė; Rokas Ereminas; Vilija Grumuldytė; Ramūnas Bolys; Eglė Ereminienė


Respiratory medicine case reports | 2017

Impact of advanced medical therapy for the outcome of an adult patient with Eisenmenger syndrome

Eglė Ereminienė; Marija Kinderytė; Skaidrius Miliauskas


Archive | 2014

Širdies ritmo variabilumo ir hemodinamikos žymenų vertė prognozuojant ūminio miokardo infarkto eigą ir baigtis sergantiesiems cukriniu diabetu

Rūta Ablonskytė Dūdonienė; Eglė Ereminienė; Julija Brazdžionytė; Remigijus Žaliūnas; Jolanta Justina Vaškelytė; Andrius Macas; Pranas Šerpytis; Germanas Marinskis; Marija Rūta Babarskienė; Jonė Venclovienė

Collaboration


Dive into the Eglė Ereminienė's collaboration.

Top Co-Authors

Avatar

Rimantas Benetis

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Giedrė Bakšytė

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Jolanta Justina Vaškelytė

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Algimantas Krisciukaitis

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Antanas Jankauskas

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Indrė Čeponienė

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Povilas Jakuška

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Remigijus Žaliūnas

Lithuanian University of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Rokas Ereminas

Lithuanian University of Health Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge